This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.

Australia and New Zealand Child Neurology Society

The Australia and New Zealand Child Neurology Society (ANZCNS) is a collaborative group of medical professionals working in the field of paediatric neurology or in allied neurosciences who are working to advance the science of paediatric neurology an

Resources and recommendations

1) Do not routinely perform electroencephalographs (EEGs) for children presenting with febrile seizures

Febrile seizures are seizures associated with fever, but without evidence of central nervous system infection. There is no evidence that epileptiform discharges (i.e. distinctive electroencephalograph patterns associated with epileptic disorders) in children with febrile seizures have any diagnostic or prognostic implications.

For instance, even among otherwise neurodevelopmentally normal children with a first complex febrile seizure (febrile seizures which are prolonged or occur multiple times within 24 hours or are confined to one side of the body) these EEG patterns are a poor predictor for epilepsy. Therefore, an EEG test should not be a routine investigation for these and other patients presenting with febrile seizures.

2) Do not routinely perform computed tomography (CT) scanning of children presenting with new onset seizures

The yield from neuroimaging of children presenting with new onset afebrile seizures is typically low, with one study finding that it led to a change in clinical management for only four percent of patients. As there are already a well-tested set of indicators for determining the likelihood of intracranial abnormalities in children with new onset unprovoked seizures, a combination of clinical history, examination, and electroencephalograph (where relevant) should first be used to determine whether the condition warrants neuroimaging.

Clinical indicators for intracranial abnormalities, which are likely to change initial patient management, include (i) a focal seizure in children aged less than three years, (ii) abnormal neurological examination, (iii) Todd’s post-ictal paresis, or (iv) presence of a condition predisposing to seizures.

In children where an intracranial abnormality is considered likely, and neuroimaging is indicated, magnetic resonance imaging (MRI) is recommended over computed tomography (CT) because (i) there is superior anatomic resolution and characterisation of pathologic processes from using MRI, and (ii) there is radiation exposure and escalated future cancer risk associated with CT.

3) Do not routinely undertake repeat blood level monitoring of antiepileptic drug (AED) treatments

The serum concentration of an antiepileptic drug (AED) varies markedly between patients taking the same dosage because of differences in people’s ability to absorb, distribute, metabolise and excrete drugs. The utility of drug blood level monitoring assumes that plasma drug level correlates better with clinical response or side effects than with dosage, or provides better information than clinical review of the patient. However, evidence from a major randomised controlled trial suggests that repeat blood level monitoring of AED treatments has no discernible impact on patient outcomes in terms of remissions from seizures or incidence of adverse effects. Other studies have also shown that there is no definitive correlation between a patient’s AED blood level and clinical efficacy.

Specific exceptions where targeted AED blood level assessment can be useful include their use in assessing compliance, titrating AEDs in complex polypharmacy regimens, or adjusting for altered AED metabolism in disease states, puberty, or pregnancy.

4) Do not routinely undertake neuroimaging for new onset primary headache without first examining for neurological abnormality

Most headaches are attributable to benign conditions. Studies suggest that the yield of neuroimaging findings in children with headache that actually change patient management is no higher than 2.5 per cent. This supports the practice of selective imaging of paediatric headache patients with clinical presentation suspicious for intracranial abnormality.

Moreover, the routine use of neuroimaging may lead to the discovery of incidental benign abnormalities, which may cause undue alarm, and headaches may be wrongfully attributed to these incidental findings. For instance, a retrospective study revealed benign neuroimaging abnormalities in approximately 20 per cent of paediatric headache patients who underwent neuroimaging.

Neuroimaging on a routine basis is therefore not indicated in children with new onset primary headaches and a normal neurological examination. It should be reserved for a selected group of children whose history and/or physical examination suggest serious intracranial pathologies.

5) Do not routinely perform electroencephalographs (EEGs) for children presenting with syncope (fainting)

Studies have found that the incidence of epileptiform discharges (i.e. distinctive EEG patterns associated with epileptic disorders) in patients with syncope is roughly similar to its incidence among healthy subjects, and that therefore EEG has very low diagnostic yield among these patients. Moreover, clinical criteria have been formulated that can differentiate syncope from seizures with very high sensitivity and specificity. Thus, guidelines recommend that an EEG should not be performed if syncope is the most likely cause of the transient loss of consciousness.

Supporting evidence

Last reviewed April 2018

How this list was developed

Following deliberations, the ANZCNS Board determined to investigate the evidence for nine priority recommendations regarding low-value clinical practices in paediatric neurology. An evidence review was developed for these recommendations and served as the basis for an online